Answer
It may temporarily increase exposure to some CYP450-metabolised medicines, especially narrow-therapeutic-index treatments such as tacrolimus or sirolimus. Tell the oncology team about all prescribed, non-prescribed and herbal products.
Sources for this answer
- IMDYLLTRA 10 milligram powder for concentrate and solution for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.